Suppr超能文献

在早发性肥胖中发现七种新的有害LEPR突变:来自法国留尼汪岛的受试者共有的ΔExon6-8,提示存在奠基者效应。

Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect.

作者信息

Huvenne Hélène, Le Beyec Johanne, Pépin Dominique, Alili Rohia, Kherchiche Patricia Pigeon, Jeannic Erwan, Frelut Marie-Laure, Lacorte Jean-Marc, Nicolino Marc, Viard Amélie, Laville Martine, Ledoux Séverine, Tounian Patrick, Poitou Christine, Dubern Béatrice, Clément Karine

机构信息

Institute of Cardiometabolism and Nutrition (H.H., R.A., J.-M.L., P.T., C.P., B.D., K.C.), Pitié-Salpêtrière Hospital, Nutrition Department, Paris F-75013, France; Sorbonne Universities (H.H., J.L.B., J.-M.L., C.P., K.C.), University Pierre et Marie Curie-Paris 6, Paris F-75006, France; INSERM (H.H., R.A., P.T., C.P., B.D., K.C.), Unité Mixte de Recherche (UMR)_S U1166, Nutriomics, Paris F-75013, France; Groupement des Hôpitaux de l'Institut Catholique de Lille (H.H.), St-Vincent de Paul Hospital, Department of Pediatrics, Lille F-59000, France; Assistance Publique-Hôpitaux de Paris (J.L.B., D.P., J.-M.L.), Pitié-Salpêtrière Hospital, Department of Biochemical Endocrinology and Oncology, Nutrigénétique, Paris F-75013, France; INSERM (J.L.B.), UMR_S U1149, Université François-Rabelais de Médecine Paris Diderot, Paris F-75018, France; Félix-Guyon-Bellepierre Hospital (P.P.K.), Department of Pediatrics, St-Denis F-97405, Reunion, France; St François d'Assise Association (E.J.), Department of Pediatric Nutrition, St-Denis F-97405, Reunion, France; Assistance Publique Hôpitaux de Paris (M.-L.F.), Bicêtre Hospital, Department of Pediatric Endocrinology and Diabetology, Kremlin-Bicêtre F-94270, France; INSERM (J.-M.L.), Integrative Biology of Atherosclerosis, UMR_S U1166, Paris F-75013, France; Mother and Child Hospital (M.N.), Department of Pediatric Endocrinology, Lyon F-69000, France; Robert Debré Hospital (A.V.), Department of Endocrinology, Reims F-51100, France; Lyon-Sud Hospital (M.L.), Department of Endocrinology, Diabetology, and Nutrition, Lyon F-69000, France; Assistance Publique-Hôpitaux de Paris (S.L.), Functional Explorations, Louis Mourier Hospital, Obesity Center, Colombes F-92700, France; and Assistance Publique-Hôpitaux de Paris (P.T., B.D.), Department of Pediatric Nutrition and Gastroenterology, Armand-Trousseau Hospital, Paris F-75571, France.

出版信息

J Clin Endocrinol Metab. 2015 May;100(5):E757-66. doi: 10.1210/jc.2015-1036. Epub 2015 Mar 9.

Abstract

CONTEXT

Infrequent mutations have been reported in the leptin receptor (LEPR) gene in humans with morbid obesity and endocrine disorders. However LEPR mutations are rarely examined in large populations from different ethnicities in a given country.

OBJECTIVE

We estimated the prevalence of LEPR mutations in French patients with severe obesity and evaluated mutated patients' phenotype.

DESIGN AND PATIENTS

We sequenced the LEPR gene in 535 morbidly obese French participants. We conducted clinical investigations to determine whether individuals with a novel shared mutation display particular characteristics relative to obesity history, body composition, hormonal functions, and the outcome of bariatric surgery.

RESULTS

We identified 12 patients with a novel LEPR mutation (p.C604G, p.L786P, p.H800_N831del, p.Y422H, p.T711NfsX18, p.535-1G>A, p.P166CfsX7). Six unrelated subjects were carriers of the p.P166CfsX7 mutation leading to deletion overlapping exons 6 to 8. All subjects originated from Reunion Island (France). Their clinical features (severe early-onset obesity, food impulsivity, and hypogonadotropic hypogonadism) did not differ from other new LEPR mutation carriers. Results concerning weight loss surgery were inconsistent in homozygous LEPR mutation carriers. Heterozygous LEPR mutation carriers exhibited variable severity of obesity and no endocrine abnormality.

CONCLUSION

Among seven newly discovered LEPR mutations in this French obese population, we identified a LEPR frameshift mutation shared by six subjects from Reunion Island. This observation suggests a founder effect in this Indian Ocean island with high prevalence of obesity and supports a recommendation for systematic screening for this mutation in morbidly obese subjects in this population.

摘要

背景

据报道,患有病态肥胖和内分泌紊乱的人类瘦素受体(LEPR)基因存在罕见突变。然而,在一个特定国家的不同种族大群体中,很少对LEPR突变进行检测。

目的

我们估计了法国严重肥胖患者中LEPR突变的患病率,并评估了突变患者的表型。

设计与患者

我们对535名病态肥胖的法国参与者的LEPR基因进行了测序。我们进行了临床调查,以确定具有新的共同突变的个体在肥胖病史、身体组成、激素功能和减肥手术结果方面是否表现出特殊特征。

结果

我们鉴定出12名患有新的LEPR突变(p.C604G、p.L786P、p.H800_N831del、p.Y422H、p.T711NfsX18、p.535-1G>A、p.P166CfsX7)的患者。6名无亲缘关系的受试者是p.P166CfsX7突变的携带者,该突变导致外显子6至8缺失重叠。所有受试者均来自留尼汪岛(法国)。他们的临床特征(严重早发性肥胖、食物冲动和低促性腺激素性性腺功能减退)与其他新的LEPR突变携带者没有差异。纯合LEPR突变携带者的减肥手术结果不一致。杂合LEPR突变携带者表现出不同程度的肥胖,且无内分泌异常。

结论

在这个法国肥胖人群中发现的7种新的LEPR突变中,我们鉴定出一种由留尼汪岛的6名受试者共享的LEPR移码突变。这一观察结果表明,在这个肥胖患病率高的印度洋岛屿存在奠基者效应,并支持对该人群中病态肥胖受试者进行该突变系统筛查的建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验